$29.99 $0.49 per serving
Product analysis
Omega JYM provides EPA and DHA that may support how the body handles blood fats, with favourable value for the amounts supplied. The oil forms are unspecified, limiting comparisons of absorption quality.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The forms of EPA and DHA are not identified, leaving absorption quality uncertain. Separately listing the omega-3 amounts does not identify their preparation.
Ingredient Transparency70
The amounts and breakdown of the main omega-3 fats are disclosed, allowing useful serving comparisons. Their forms remain unspecified, so preparation details are less clear.
Value For Money75
EPA and DHA offer favourable value for the serving cost. The additional omega-3 component cannot be compared reliably.
Customer Satisfaction79
Customer ratings are positive across several hundred responses. That provides a useful picture of satisfaction without demonstrating a particular health effect.
Product Focus75
The strongest connection is to how the body handles blood fats. Possible effects on inflammation or attention depend on repeated intake and do not establish immediate benefits.
- Format
Softgel - Container
- 120 Softgel(s)
- Per serving
- $0.49
- Customer rating
- 4.8 · 451 ratings
Goals
Impact
Highest effect
Fish Oil · 2600 mg
EPA and DHA can lower triglycerides, which is the main cardiovascular role supported here. The separately declared active amounts receive recognition, but total oil weight is not an additional active dose. Trials used particular exposures and populations, so the recorded triglyceride contribution does not demonstrate prevention of cardiovascular events or improved heart rhythm.
How this product is rated for Cardiovascular Support
Ingredient fit83
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
Relevant ingredients sit within a broader formula containing other actives, which limits its focus on this goal.
Dose adequacy
The ingredients included in this finding meet the saved amount criteria; this does not establish extra benefit from larger amounts.
Pathways60
The strongest recorded coverage concerns triglyceride metabolism; this is a mechanism finding, not proof of fewer cardiovascular events.
Depth
The strongest recorded coverage concerns triglyceride metabolism; this is a mechanism finding, not proof of fewer cardiovascular events.
Breadth
One cardiovascular mechanism reaches the coverage threshold, with limited coverage of the others.
Evidence83
EPA declared active provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
EPA declared active provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Impact
Highest effect
EPA (Eicosapentaenoic Acid) · 750 mg
EPA and DHA relate mainly to triglyceride metabolism, with more limited evidence for changes in blood pressure and other vascular measures. Their declared active amounts, rather than total fish-oil mass, establish the relevant exposure. Routine fish-oil supplementation has not shown a general reduction in major cardiovascular events, and prescription purified EPA findings cannot be transferred to this product.
How this product is rated for Heart Health
Ingredient fit81
EPA (Eicosapentaenoic Acid), DHA (Docosahexaenoic Acid) provide the main connection to heart health; other active ingredients broaden the formula beyond this goal
Goal fit
EPA (Eicosapentaenoic Acid), DHA (Docosahexaenoic Acid) provide the main connection to heart health; other active ingredients broaden the formula beyond this goal
Dose adequacy
The relevant amounts provide a partial contribution across the formula; higher amounts are not automatically more beneficial.
Pathways60
Triglyceride metabolism is the strongest connection in the saved findings; this describes the ingredient roles, not a guaranteed effect.
Depth
Triglyceride metabolism is the strongest connection in the saved findings; this describes the ingredient roles, not a guaranteed effect.
Breadth
The main areas represented are triglyceride metabolism; other aspects have less support in this formula.
Evidence100
EPA (Eicosapentaenoic Acid) provides the strongest relevant evidence here, with the population and benefit limits described above.
Evidence strength
EPA (Eicosapentaenoic Acid) provides the strongest relevant evidence here, with the population and benefit limits described above.
Studied preparation
The contributing ingredient preparations match those recognized in the supplied comparison; this does not establish efficacy of the finished product.
Formulation logic100
The relevant ingredients do not depend on a missing partner in the supplied findings. No configured ingredient conflict was identified in the supplied findings.
Partner coverage
The relevant ingredients do not depend on a missing partner in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The contributing ingredients have meaningful declared amounts for comparison, without proving a cardiovascular benefit.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Impact
High effect
Fish Oil · 2600 mg
EPA and DHA can contribute to changes in inflammatory fatty-acid signalling, with reductions in inflammation markers reported across trials. This serving declares 750 mg of each, and the saved findings treat them separately. Results across fish-oil studies are inconsistent, so these marker changes do not establish routine clinical benefit. Additional fat-panel amounts do not establish extra EPA or DHA.
How this product is rated for Inflammation
Ingredient fit72
EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) provide the relevant ingredient findings. Amounts and the wider formula determine the degree of alignment.
Goal fit
Relevant ingredients form part of a broader formula with other purposes.
Dose adequacy
The relevant amounts provide partial alignment with the saved reference amounts, with some below the studied exposure.
Pathways43
The main connection is through fatty-acid signalling. Coverage is concentrated in fatty-acid signalling, rather than spread broadly across the evaluated routes.
Depth
The strongest finding concerns fatty-acid signalling.
Breadth
Coverage is concentrated in fatty-acid signalling, rather than spread broadly across the evaluated routes.
Evidence70
EPA (eicosapentaenoic acid) leads the evidence finding. The reviewed material is recognized in the saved findings.
Evidence strength
EPA (eicosapentaenoic acid) provides the leading evidence finding; the supported outcomes and populations limit how broadly it applies.
Studied preparation
The preparations receiving this finding are treated as matching the reviewed material; this does not establish the same daily regimen.
Formulation logic100
The relevant ingredients have no unmet partner requirement or configured conflict. Their amount thresholds do not establish clinical benefit.
Partner coverage
The relevant ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The ingredients counted here clear the saved amount threshold; that threshold does not prove an effective dose for every user.
Impact
High effect
DHA and EPA are omega-3 fats with roles relevant to brain function, but their supplied cognitive evidence concerns repeated intake rather than immediate concentration. Positive DHA findings involved low-intake adults using it for months, while EPA evidence does not establish routine acute focus enhancement. The saved amounts and pathway findings therefore do not demonstrate a focus benefit from one serving.
How this product is rated for Mental Focus
Ingredient fit74
Relevant ingredients share the formula with other purposes; its links to several goals also reduce its focus specificity. Amounts provide only partial coverage of the saved comparison.
Goal fit
Relevant ingredients share the formula with other purposes; its links to several goals also reduce its focus specificity.
Dose adequacy
The declared amounts only partly meet the saved comparison; this measures exposure against reference amounts, not the probability of benefit.
Pathways58
The strongest saved coverage concerns synaptic plasticity and neuroprotection; this is not proof of improved attention.
Depth
The strongest saved coverage concerns synaptic plasticity and neuroprotection; this is not proof of improved attention.
Breadth
Only one pathway reaches the saved coverage threshold, so the findings are concentrated rather than broad.
Evidence56
The supplied scientific qualifications limit what the saved favourable findings establish about immediate attention. Some declarations do not match studied preparations.
Evidence strength
The supplied scientific qualifications limit what the saved favourable findings establish about immediate attention.
Studied preparation
The saved preparation finding is incomplete for DHA (Docosahexaenoic Acid); generic declarations do not establish equivalence to studied material.
Formulation logic100
No configured ingredient conflict is identified in the supplied findings. No missing partner was identified.
Partner coverage
No missing partner is identified for the ingredients included in the saved finding; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict is identified in the supplied findings.
Effective doses
All ingredients counted by this rule meet its minimum amount threshold; that threshold is not a clinically proven dose for immediate focus.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 25 Calorie(s) | |
Total Fat | 2.5 Gram(s) | |
Total Fish Oil | 2600 mg | |
Eicosapentaenoic Acid | 750 mg | |
Docosahexaenoic Acid | 750 mg | |
Docosapentaenoic Acid | 150 mg |
EPA (Eicosapentaenoic Acid) · 750 mg OverallScore53
A serving provides 750 mg of EPA, about 28.8% of the fish oil. The whole-product serving price works out to about $0.67 per gram of EPA.
How this ingredient is rated
Active Ingredient Quality & Bioavailability40
The EPA molecular form is not established in the saved information. EPA makes up about 28.8% of the 2600 mg of fish oil per serving. The saved information does not confirm an antioxidant for the oil.
Molecular Form and Bioavailability
The EPA molecular form is not established in the saved information.
EPA Concentration Density
EPA makes up about 28.8% of the 2600 mg of fish oil per serving.
Oxidation Protection
The saved information does not confirm an antioxidant for the oil.
Dose, Safety & Label Transparency52
Each serving has 750 mg of EPA and 750 mg of DHA. The saved information does not confirm a purification or qualifying contaminant-testing claim.
Absolute EPA Dose per Serving
Each serving provides 750 mg of EPA, a higher amount.
EPA-Centric Ratio
Each serving has equal amounts of EPA and DHA: 750 mg of each.
Purity and Contaminant Testing
The saved information does not confirm a purification or qualifying contaminant-testing claim.
Value80
Based on the whole-product serving price, the cost works out to about $0.67 per gram of EPA.
Price per Gram of EPA
Based on the whole-product serving price, the cost works out to about $0.67 per gram of EPA.
Fish Oil · 2600 mg OverallScore53
A serving provides 1,500 mg of EPA and DHA combined in 2,600 mg of fish oil. That is about 57.7% of the oil, and the whole-product price works out to about $0.33 per gram of EPA and DHA.
How this ingredient is rated
Active Ingredient Quality & Bioavailability14
The molecular form of the oil is not established in the saved facts. Independent testing is not established in the saved facts.
Omega-3 Molecular Form
The molecular form of the oil is not established in the saved facts.
Purification & Filtration Method
The saved evaluation does not establish a qualifying purification claim for the oil.
Third-Party Purity & Potency Verification
Independent testing is not established in the saved facts.
Source & Sustainability
A named fish source is recognized in the saved evaluation; the catch method is not established.
Dose, Safety & Label Transparency69
A serving provides 1,500 mg of EPA and DHA combined. EPA and DHA together account for about 57.7% of the 2,600 mg of fish oil per serving.
Total Active Omega-3 Dose (EPA + DHA)
A serving provides 1,500 mg of EPA and DHA combined.
Omega-3 Potency & Concentration
EPA and DHA together account for about 57.7% of the 2,600 mg of fish oil per serving.
EPA & DHA Individual Disclosure
The saved facts list EPA and DHA separately: 750 mg of EPA and 750 mg of DHA per serving.
Oxidation Protection (Stabilizers)
The saved facts do not establish a qualifying antioxidant; the oil’s oxidation status remains unknown.
Value100
The whole-product price is about $0.33 per gram of combined EPA and DHA.
Cost Per Gram of Active EPA + DHA
The whole-product price is about $0.33 per gram of combined EPA and DHA.
DHA · 750 mg OverallScore43
Each serving provides 750 mg of DHA. The whole-product price works out to about $0.67 per gram of DHA.
How this ingredient is rated
Active Ingredient Quality & Bioavailability8
The DHA chemical form is not established in the saved facts. The available facts do not establish oil concentration.
DHA Chemical Form & Bioavailability
The saved facts do not establish the DHA chemical form; oil identity alone does not establish it.
Oxidation Protection & Stability
A qualifying protective antioxidant was not established by the saved evidence; actual oxidation is unknown.
Oil Concentration & Purity
The available amounts do not establish the share of oil that is total omega-3, so concentration remains unknown.
Dose, Safety & Label Transparency60
Each serving provides 750 mg of DHA. A fish or krill source is recorded. No qualifying contaminant-testing claim was established.
DHA Absolute Dosage
Each serving provides 750 mg of DHA.
Purity & Heavy Metal Verification
The saved evidence does not establish a qualifying contaminant-testing or distillation claim; contaminant levels remain unknown.
Ingredient Source Transparency
The saved facts record a fish or krill source for the DHA.
Value80
The whole-product price works out to about $0.67 per gram of DHA.
Price per Gram of DHA
The whole-product price works out to about $0.67 per gram of DHA.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
- EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
- Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
- Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.